Capricor Therapeutics, Inc. (NASDAQ:CAPR – Get Free Report)’s share price fell 6.7% during trading on Wednesday . Industrial Alliance Securities set a $48.00 price target on Capricor Therapeutics in a report on Wednesday, December 3rd. Get Capricor Therapeutics alerts:View Our Latest Report on Capricor TherapeuticsCapricor Therapeutics Stock PerformanceThe company’s 50 day simple moving average is $22.32 and its 200 day simple moving average is $12.26. Capricor Therapeutics Company Profile(Get Free Report)Capricor Therapeutics, Inc is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for cardiovascular and rare diseases. Recommended StoriesReceive News & Ratings for Capricor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capricor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.